Cited by 54Hypothalamic control of reproductive hormonesSexual Differentiation and DisordersHormonal and reproductive studies

Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)

Reiter, Edward O., Mauras, Nelly, McCormick, Ken, Kulshreshtha, Bindu, Amrhein, James, De Luca, Francesco, O'Brien, Sandra, Armstrong, Jon +1 more·2010·Journal of Pediatric Endocrinology and Metabolism

Abstract

OBJECTIVE: To evaluate the efficacy, tolerability, and pharmacokinetics of bicalutamide plus anastrozole in young males with testotoxicosis. METHODS: This was a multicenter, open-label, single-arm, 12-month, Phase II pilot trial in 14 males (2-9 years) with testotoxicosis treated with bicalutamide (12.5, 25, 50, or 100 mg) and anastrozole (0.5 or 1 mg) daily. The primary outcome was change in growth rate. RESULTS: At 1 year, the mean (standard deviation) change from baseline in growth rate was -1.6 (+/- 5.1) cm/year and -0.1 (+/- 1.8) SD units, and in bone maturation was -2.3 (+/- 0.5) years. The bone age/chronological age ratio was reduced from 2.1 (+/- 0.6) at baseline to 1.0 (+/- 0.4) (p = 0.00013). Steady-state trough R-bicalutamide and anastrozole concentrations were attained by Day 21 and 8, respectively. Gynecomastia (42.9%) and breast tenderness (12.5%) were the most common treatment-related adverse events. CONCLUSIONS: Treatment of testotoxicosis with bicalutamide plus anastrozole resulted in slower growth rate.

Integrity signals

Registry

Crossref · 10.1515/jpem.2010.161

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Uncontrolled studies using anastrozole, testolactone or letrozole have shown some evidence for a positive effect on sperm concentration and motility.

    “Uncontrolled studies using anastrozole, testolactone or letrozole have shown some evidence for a positive effect on sperm concentration and motility [49-51].”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [49]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reiter, E. O., Mauras, N., McCormick, K., Kulshreshtha, B., Amrhein, J., De Luca, F., O'Brien, S., Armstrong, J., & Melezinkova, H.
Affiliations
  • Tufts University (US)
  • Nemours Children's Clinic (US)
  • University of Alabama at Birmingham (US)
  • All India Institute of Medical Sciences (IN)
  • AstraZeneca (United Kingdom) (GB)
Venue
Journal of Pediatric Endocrinology and Metabolism
Published
2010-01
Volume
23
Issue
10
Pages
999-1009
ISSN
  • 0334-018X (ISSN-L)
  • 2191-0251
OpenAlex
W2091555378
Cited by
54
References
28
Citations by year
2025: 1 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 2 · 2015: 8 · 2013: 3
FWCI
3.41
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
testotoxicosis, gonadotropin-independent precocious puberty, bicalutamide, anastrozole, androgen deprivation therapy, growth rate, skeletal maturation, bone age, pharmacokinetics, gynecomastia, pediatric boys
MeSH terms
Anastrozole, Anilides, Bone Development, Child, Child, Preschool, Drug Therapy, Combination, Gonadotropins, Growth, Humans, Male, Nitriles, Pilot Projects, Puberty, Precocious, Tosyl Compounds, Triazoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review